Literature DB >> 23418747

May the evaluation of nitrosative stress through selective increase of 3-nitrotyrosine proteins other than nitroalbumin and dominant tyrosine-125/136 nitrosylation of serum α-synuclein serve for diagnosis of sporadic Parkinson's disease?

Emilio Fernández1, José-Manuel García-Moreno, Angel Martín de Pablos, José Chacón.   

Abstract

Nitrosative stress, where nitrosylation of tyrosine (Tyr) leading to 3-nitrotyrosine proteins or free 3-nitrotyrosine is the most prominent change, has been proposed as a pathogenic mechanism in Parkinson's disease (PD). Levels of 3-nitrotyrosine proteins in serum and cerebrospinal fluid (CSF) of patients with PD have not been studied. Nitrosative stress-induced protein changes in serum and CSF were analyzed in patients with PD (n=54) and controls (n=40). Herein, we demonstrate the presence of nitrosative stress in serum and CSF of patients with early PD leading to selective increase of 3-nitrotyrosine proteins other than nitroalbumin, without free 3-nitrotyrosine (Hoehn-Yahr stage 1, p<0.05; stage 2, p<0.01). Among 3-nitrotyrosine proteins, nitro-α-synuclein (N-αSyn) was detected in serum, not CSF, and the sites of Tyr nitrosylation were observed to be modified in patients with early PD. Thus, the intensity of nitrosylation of Tyr125/136 residues is enhanced (stage 1, p<0.05; stage 2, p<0.01), and that of the Tyr39 site is reduced (stage 1, p<0.05), and the ratio between both parameters (α-synuclein with nitrosylated tyrosines 125 and 136 [N-αSyn-Tyr125/136]:α-synuclein with nitrosylated tyrosine 39 [N-αSyn-Tyr39] ratio) is significantly higher in patients with early PD (p<0.01). These observations lead to the hypothesis that evaluating nitrosative stress through enhanced levels of 3-nitrotyrosine proteins in serum and CSF without changes in nitroalbumin, together with the profile of tyrosine nitrosylation of serum αSyn characterized by dominant nitrosylation of Tyr125/136, could serve for the diagnosis of sporadic PD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23418747      PMCID: PMC3763231          DOI: 10.1089/ars.2013.5250

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  9 in total

1.  Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects.

Authors:  Brit Mollenhauer; Ellen Trautmann; Peggy Taylor; Paul Manninger; Friederike Sixel-Döring; Jens Ebentheuer; Claudia Trenkwalder; Michael G Schlossmacher
Journal:  Neurosci Lett       Date:  2012-11-10       Impact factor: 3.046

2.  Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease.

Authors:  Alessandro Prigione; Fabrizio Piazza; Laura Brighina; Barbara Begni; Alessio Galbussera; Jacopo C Difrancesco; Simona Andreoni; Roberto Piolti; Carlo Ferrarese
Journal:  Neurosci Lett       Date:  2010-04-24       Impact factor: 3.046

Review 3.  Oxidative stress in Parkinson's disease.

Authors:  Peter Jenner
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

4.  Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

Authors:  B I Giasson; J E Duda; I V Murray; Q Chen; J M Souza; H I Hurtig; H Ischiropoulos; J Q Trojanowski; V M Lee
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

5.  Free 3-nitrotyrosine causes striatal neurodegeneration in vivo.

Authors:  M J Mihm; B L Schanbacher; B L Wallace; L J Wallace; N J Uretsky; J A Bauer
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

6.  Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.

Authors:  Omar M A El-Agnaf; Sultan A Salem; Katerina E Paleologou; Leanne J Cooper; Nigel J Fullwood; Mark J Gibson; Martin D Curran; Jennifer A Court; David M A Mann; Shu-ichi Ikeda; Mark R Cookson; John Hardy; David Allsop
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

7.  May serum levels of advanced oxidized protein products serve as a prognostic marker of disease duration in patients with idiopathic Parkinson's disease?

Authors:  José-Manuel García-Moreno; Angel Martín de Pablos; María-Isabel García-Sánchez; Carolina Méndez-Lucena; Fátima Damas-Hermoso; Macarena Rus; José Chacón; Emilio Fernández
Journal:  Antioxid Redox Signal       Date:  2012-12-07       Impact factor: 8.401

Review 8.  Protein tyrosine nitration--an update.

Authors:  Harry Ischiropoulos
Journal:  Arch Biochem Biophys       Date:  2008-10-30       Impact factor: 4.013

9.  α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.

Authors:  Tim Bartels; Joanna G Choi; Dennis J Selkoe
Journal:  Nature       Date:  2011-08-14       Impact factor: 49.962

  9 in total
  11 in total

1.  May the thyroid gland and thyroperoxidase participate in nitrosylation of serum proteins and sporadic Parkinson's disease?

Authors:  Emilio Fernández; José-Manuel García-Moreno; Angel Martín de Pablos; José Chacón
Journal:  Antioxid Redox Signal       Date:  2014-09-30       Impact factor: 8.401

Review 2.  An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels.

Authors:  Iris N Serratos; Elizabeth Hernández-Pérez; Carolina Campos; Michael Aschner; Abel Santamaría
Journal:  Mol Neurobiol       Date:  2021-11-08       Impact factor: 5.682

Review 3.  Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome.

Authors:  Gerwyn Morris; Michael Berk; Hans Klein; Ken Walder; Piotr Galecki; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-06-23       Impact factor: 5.590

Review 4.  Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Authors:  Félix J Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Front Cell Neurosci       Date:  2014-11-11       Impact factor: 5.505

5.  Tollip, an early regulator of the acute inflammatory response in the substantia nigra.

Authors:  Marie Humbert-Claude; D Duc; D Dwir; L Thieren; J Sandström von Tobel; C Begka; F Legueux; D Velin; M H Maillard; K Q Do; F Monnet-Tschudi; L Tenenbaum
Journal:  J Neuroinflammation       Date:  2016-12-07       Impact factor: 8.322

6.  GYY4137, an H2S Slow-Releasing Donor, Prevents Nitrative Stress and α-Synuclein Nitration in an MPTP Mouse Model of Parkinson's Disease.

Authors:  Xiaoou Hou; Yuqing Yuan; Yulan Sheng; Baoshi Yuan; Yali Wang; Jiyue Zheng; Chun-Feng Liu; Xiaohu Zhang; Li-Fang Hu
Journal:  Front Pharmacol       Date:  2017-10-30       Impact factor: 5.810

Review 7.  Cellular and Molecular Events Leading to Paraquat-Induced Apoptosis: Mechanistic Insights into Parkinson's Disease Pathophysiology.

Authors:  Wesley Zhi Chung See; Rakesh Naidu; Kim San Tang
Journal:  Mol Neurobiol       Date:  2022-03-19       Impact factor: 5.682

8.  Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson's Disease.

Authors:  Emilio Fernández-Espejo; Fernando Rodríguez de Fonseca; Juan Suárez; Eduardo Tolosa; Dolores Vilas; Iban Aldecoa; Joan Berenguer; Fátima Damas-Hermoso
Journal:  Antioxidants (Basel)       Date:  2021-05-01

9.  A Cystine-Rich Whey Supplement (Immunocal®) Provides Neuroprotection from Diverse Oxidative Stress-Inducing Agents In Vitro by Preserving Cellular Glutathione.

Authors:  Aimee N Winter; Erika K Ross; Vamsi Daliparthi; Whitney A Sumner; Danielle M Kirchhof; Evan Manning; Heather M Wilkins; Daniel A Linseman
Journal:  Oxid Med Cell Longev       Date:  2017-08-15       Impact factor: 6.543

Review 10.  Neurons and Glia Interplay in α-Synucleinopathies.

Authors:  Panagiota Mavroeidi; Maria Xilouri
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.